EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Surface-targeted complement modulation at biomedical interfaces

Ekaterina Umnyakova, Jannes Felsch, Daniel Ricklin

Trends in Pharmacological Sciences · 2026-08 · 47 (8) · 890-905

DOI: 10.1016/j.tips.2026.06.005 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Pharmacological Sciences, 2026-08. Verfasst von Ekaterina Umnyakova und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland. Electronic address: ekaterina.umnyakova@unibas.ch. Hauptthemen laut MEDLINE: Complement Activation, Complement System Proteins, Biocompatible Materials. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 115 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss National Science Foundation, Novartis AG, University of Basel.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The complement system is essential for distinguishing self-tissue from foreign threats; however, complement activation on biomedical surfaces such as implants, transplants, or drug-delivery systems may lead to severe thromboinflammatory complications. Unlike systemic complement inhibitors, surface-targeted strategies remain scarce, despite their potential advantages regarding safety and efficacy. Recent years have seen the emergence of diverse surface-targeting approaches that impair different mechanisms underlying complement-mediated complications. These strategies, ranging from surface coatings to inhibitors targeting complement-tagged surfaces, are progressing from conceptual development to clinical application. In this review, we provide a comprehensive overview of complement-activation mechanisms on biomedical surfaces, highlight ongoing clinical investigations, and discuss a broad spectrum of emerging approaches to prevent adverse complement activation on biomedical interfaces.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Complement ActivationComplement System ProteinsBiocompatible MaterialsHumansAnimalsSurface PropertiesDrug Delivery Systems

Stichwörter der Autor:innen

biomaterialscomplementgraft rejectionimmune modulationnonself surfacesthromboinflammation

Substanzen

Complement System ProteinsBiocompatible Materials

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland. Electronic address: ekaterina.umnyakova@unibas.ch.
  • Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.

Förderung

  • Swiss National Science Foundation
  • Novartis AG
  • University of Basel
  • Novartis Foundation

Zitieren

APA

Umnyakova, E., Felsch, J., & Ricklin, D. (2026). Surface-targeted complement modulation at biomedical interfaces. Trends in Pharmacological Sciences, 47(8), 890-905. https://doi.org/10.1016/j.tips.2026.06.005

Vancouver

Umnyakova E, Felsch J, Ricklin D. Surface-targeted complement modulation at biomedical interfaces. Trends in Pharmacological Sciences. 2026;47(8):890-905. doi:10.1016/j.tips.2026.06.005

BibTeX
@article{Umnyakova2026,
  author = {Umnyakova, Ekaterina and Felsch, Jannes and Ricklin, Daniel},
  title = {Surface-targeted complement modulation at biomedical interfaces},
  journal = {Trends in Pharmacological Sciences},
  year = {2026},
  volume = {47},
  number = {8},
  pages = {890--905},
  doi = {10.1016/j.tips.2026.06.005}
}
Kostenlos starten →